Balcinrenone

巴昔利酮

Report date: 2024/03/29 13:22:21
NME

Base Information

Drug NameBalcinrenone
Drug Alias NameAZD-9977
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMineralocorticoid receptor modulators
TargetsMineralocorticoid receptor
Therapy Area/IndicationsHeart Failure, DiastolicHeart FailureCardiovascular Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[23] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Plc
Inactive CompaniesN/A
Active IndicationsHeart FailureRenal Insufficiency, ChronicRenal Insufficiency +[4] 
Inactive IndicationsHeart Failure, DiastolicCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A